These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7688304)

  • 1. Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58.
    Bonci A; Bracci L; Caudai C; Lozzi L; Moschettini D; Niccolai N; Scarselli M; Valensin PE; Neri P
    Eur J Biochem; 1993 Jul; 215(2):383-7. PubMed ID: 7688304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.
    Lozzi L; Rustici M; Corti M; Cusi MG; Valensin PE; Bracci L; Santucci A; Soldani P; Spreafico A; Neri P
    Arch Virol; 1990; 110(3-4):271-6. PubMed ID: 1690535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
    Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies.
    Meyer H; Sundqvist VA; Pereira L; Mach M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2375-83. PubMed ID: 1383409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope.
    Meyer H; Masuho Y; Mach M
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2443-50. PubMed ID: 1700066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of epitopes within the amino acid sequence of the Epstein-Barr virus major envelope glycoprotein, gp340, recognized by hyperimmune rabbit sera.
    Pither RJ; Nolan L; Tarlton J; Walford J; Morgan AJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1409-15. PubMed ID: 1376768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
    Ohlin M; Sundqvist VA; Mach M; Wahren B; Borrebaeck CA
    J Virol; 1993 Feb; 67(2):703-10. PubMed ID: 7678304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.
    Wagner B; Kropff B; Kalbacher H; Britt W; Sundqvist VA; Ostberg L; Mach M
    J Virol; 1992 Sep; 66(9):5290-7. PubMed ID: 1323695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.
    Lantto J; Fletcher JM; Ohlin M
    J Gen Virol; 2002 Aug; 83(Pt 8):2001-2005. PubMed ID: 12124464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond.
    Speckner A; Kropff B; Knör S; Mach M
    J Gen Virol; 2000 Nov; 81(Pt 11):2659-2663. PubMed ID: 11038377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a major antigenic region on gp55 of human cytomegalovirus.
    Silvestri M; Sundqvist VA; Rudén U; Wahren B
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3017-23. PubMed ID: 1662693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B.
    Emini EA; Luka J; Armstrong ME; Keller PM; Ellis RW; Pearson GR
    Virology; 1987 Apr; 157(2):552-5. PubMed ID: 3029988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of B-cell epitopes on the polypeptide chain of the Epstein-Barr virus major envelope glycoprotein and candidate vaccine molecule gp340.
    Pither RJ; Zhang CX; Shiels C; Tarlton J; Finerty S; Morgan AJ
    J Virol; 1992 Feb; 66(2):1246-51. PubMed ID: 1370550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin.
    Baboonian C; Venables PJ; Williams DG; Williams RO; Maini RN
    Ann Rheum Dis; 1991 Nov; 50(11):772-5. PubMed ID: 1722966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7.
    Franti M; Aubin JT; De Saint-Maur G; Kosuge H; Yamanishi K; Gautheret-Dejean A; Garbarg-Chenon A; Huraux JM; Agut H
    J Clin Microbiol; 2002 Jan; 40(1):44-51. PubMed ID: 11773091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
    Lantto J; Fletcher JM; Ohlin M
    Virology; 2003 Jan; 305(1):201-9. PubMed ID: 12504553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.
    Utz U; Britt W; Vugler L; Mach M
    J Virol; 1989 May; 63(5):1995-2001. PubMed ID: 2467992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).
    Rumpold H; Rhodes GH; Bloch PL; Carson DA; Vaughan JH
    J Immunol; 1987 Jan; 138(2):593-9. PubMed ID: 2432130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies.
    Tunbäck P; Liljeqvist JA; Löwhagen GB; Bergström T
    J Gen Virol; 2000 Apr; 81(Pt 4):1033-40. PubMed ID: 10725430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.